The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 54 results:
Author Title Type [ Year(Desc)]
Filters: Author is Walsh, Thomas J  [Clear All Filters]
2010
Demchok, J. P., Meletiadis J., Roilides E., & Walsh T. J. (2010).  Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp.. Mycoses. 53(3), 239-45.
Simitsopoulou, M., Georgiadou E., Walsh T. J., & Roilides E. (2010).  Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.. Med Mycol. 48(5), 720-4.
Meletiadis, J., Pournaras S., Roilides E., & Walsh T. J. (2010).  Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumi. Antimicrob Agents Chemother. 54(2), 602-9.
Antachopoulos, C., Demchok J. P., Roilides E., & Walsh T. J. (2010).  Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi.. Mycoses. 53(4), 321-8.
Katragkou, A., Kruhlak M. J., Simitsopoulou M., Chatzimoschou A., Taparkou A., Cotten C. J., et al. (2010).  Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.. J Infect Dis. 201(12), 1941-9.
2011
Chatzimoschou, A., Katragkou A., Simitsopoulou M., Antachopoulos C., Georgiadou E., Walsh T. J., et al. (2011).  Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.. Antimicrob Agents Chemother. 55(5), 1968-74.
Saoulidis, S., Simitsopoulou M., Dalakiouridou M., Walsh T. J., L Wheat J., Papaioannidou P., et al. (2011).  Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model.. Mycoses. 54(5), e486-92.
Simitsopoulou, M., Roilides E., Georgiadou E., Paliogianni F., & Walsh T. J. (2011).  Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus.. Med Mycol. 49(2), 176-85.
Katragkou, A., Simitsopoulou M., Chatzimoschou A., Georgiadou E., Walsh T. J., & Roilides E. (2011).  Effects of interferon-γ and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells.. Cytokine. 55(3), 330-4.
Simitsopoulou, M., Roilides E., & Walsh T. J. (2011).  Immunomodulatory properties of antifungal agents on phagocytic cells.. Immunol Invest. 40(7-8), 809-24.
Stergiopoulou, T., Meletiadis J., Sein T., Papaioannidou P., Walsh T. J., & Roilides E. (2011).  Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus.. Antimicrob Agents Chemother. 55(12), 5923-9.
2012
Gamaletsou, M. N., Kontoyiannis D. P., Sipsas N. V., Moriyama B., Alexander E., Roilides E., et al. (2012).  Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011).. Clin Infect Dis. 55(10), 1338-51.
Spellberg, B., Ibrahim A., Roilides E., Lewis R. E., Lortholary O., Petrikkos G., et al. (2012).  Combination therapy for mucormycosis: why, what, and how?. Clin Infect Dis. 54 Suppl 1, S73-8.
Petrikkos, G., Skiada A., Lortholary O., Roilides E., Walsh T. J., & Kontoyiannis D. P. (2012).  Epidemiology and clinical manifestations of mucormycosis.. Clin Infect Dis. 54 Suppl 1, S23-34.
Roilides, E., Kontoyiannis D. P., & Walsh T. J. (2012).  Host defenses against zygomycetes.. Clin Infect Dis. 54 Suppl 1, S61-6.
Lewis, R. E., Lortholary O., Spellberg B., Roilides E., Kontoyiannis D. P., & Walsh T. J. (2012).  How does antifungal pharmacology differ for mucormycosis versus aspergillosis?. Clin Infect Dis. 54 Suppl 1, S67-72.
Tragiannidis, A., Roilides E., Walsh T. J., & Groll A. H. (2012).  Invasive aspergillosis in children with acquired immunodeficiencies.. Clin Infect Dis. 54(2), 258-67.
Meletiadis, J., Al-Saigh R., Velegraki A., Walsh T. J., Roilides E., & Zerva L. (2012).  Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.. Antimicrob Agents Chemother. 56(1), 403-10.
Steinbach, W. J., Roilides E., Berman D., Hoffman J. A., Groll A. H., Bin-Hussain I., et al. (2012).  Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.. Pediatr Infect Dis J. 31(12), 1252-7.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.